Imbruvica 140 MG capsule 90S
Ended Awarded
- Contract number
- SPE2DB25FQHZC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,117
Award facts
- Contract value 100% obligated
- $8,116.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,116.87 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) on August 18, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the location of performance for this order—is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates its capability to meet diverse pharmaceutical supply requirements, ranging from specialty medications to brand-name and generic drugs across multiple therapeutic domains. This delivery order for Imbruvica, a specialty oncology medication, exemplifies the company's role in supplying specialized pharmaceutical commodities through the DLA's medical supply chain to support Defense Health Agency and other federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FQHZC?
SPE2DB25FQHZC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FQHZC worth?
The government has obligated $8,117 on SPE2DB25FQHZC.
Is contract SPE2DB25FQHZC an order under another contract?
Yes. SPE2DB25FQHZC is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQHZC competed?
The extent of competition for SPE2DB25FQHZC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award